Daily press briefings were held from the conference during morning and afternoon tea breaks. These small round table discussions provided journalists an opportunity to speak directly with key speakers. View the press briefings below.
MONDAY, 16 April
Microbicides as a woman-controlled HIV prevention: What lessons have we learnt from recent trials and what are the implications?
Speaker:
Salim S. Abdool Karim, Pro Vice Chancellor (Research) at the University of KwaZulu-Natal
and Director of CAPRISA - Centre for the AIDS Program of Research, South Africa
Day 1, first Press briefing with Salim Abdool Karim
Oral PrEP, a summary of trials conducted and what's ahead.
Speakers:
Connie Celum
, Professor of Global Health and Medicine at University of Washington
Kenneth Mayer,
Medical Research Director, Co-Chair of The Fenway Institute
DAY 1, second Press briefing with Kenneth Mayer and Connie Celum
TUESDAY, 17 April
Making access a reality for those in need.
Speakers:
Ms Milly Katana (MPH, MA, MBA), Public Health Specialist,
John Snow Incorporated, Uganda
Helen Rees, Executive Director, Wits Reproductive Health and HIV Institute, South Africa
DAY 2, FIRST PRESS BRIEFING with helen rees and milly katana
Rectal microbicides, an overview.
Speakers:
Ian McGowan
, M.D., Ph.D., F.R.C.P., co-principal investigator of the University of Pittsburgh-based Microbicide Trials Network
Jim Pickett
, Executive Director of the International Rectal Microbicide Advocates
DAY 2, second Press briefing with JIM PICKETT and Ian McGowan
WEDNESDAY, 18 April
10:30am-11:00am:
Who pays? Global resourcing for new HIV prevention technology
the future of prevention trials in HIV.
Speakers:
Dr Debrework Zewdie
, Deputy Executive Director, The Global Fund to Fight AIDS, Tuberculosis, and Malaria, Switzerland
Professor Richard Hayes
, Professor of Epidemiology & International Health, London School of Hygiene & Tropical Medicine, UK
DAY 3, first Press briefing with debrework zewdie and richard hayes
3:30pm-4:00pm:
HIV and hormonal contraceptives and multi-prevention technologies
Speakers:
Gustavo Doncel, M.D. Deputy Director, Preclinical Research CONRAD
Henry Gabelnick
, Ph.D, Executive Director CONRAD
DAY 3, second Press briefing with Gustavo doncel and henry gabelnick
Speaker bios and photos available upon request.
